These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33841505)

  • 1. TRIB3 Promotes the Malignant Progression of Bladder Cancer: An Integrated Analysis of Bioinformatics and
    Yang J; Lin J; An J; Zhao Y; Jing S; Yu M; Zhu Y; Yao Y
    Front Genet; 2021; 12():649208. PubMed ID: 33841505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
    Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
    Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tribbles pseudokinase 3 (
    Wang RQ; He FZ; Meng Q; Lin WJ; Dong JM; Yang HK; Yang Y; Zhao M; Qiu WT; Xin YJ; Zhou ZL
    Ann Transl Med; 2021 Aug; 9(15):1253. PubMed ID: 34532390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway.
    Wang S; Wang C; Li X; Hu Y; Gou R; Guo Q; Nie X; Liu J; Zhu L; Lin B
    Cancer Cell Int; 2020; 20():418. PubMed ID: 32874132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
    Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
    Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
    Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
    Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.
    Shen P; Zhang TY; Wang SY
    Exp Ther Med; 2021 Apr; 21(4):313. PubMed ID: 33717256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
    Bao XY; Sun M; Peng TT; Han DM
    Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression.
    Wang WL; Hong GC; Chien PJ; Huang YH; Lee HT; Wang PH; Lee YC; Chang WW
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33334065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect.
    Xing Y; Luo P; Hu R; Wang D; Zhou G; Jiang J
    Cancer Manag Res; 2020; 12():13195-13206. PubMed ID: 33380827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.
    Wennemers M; Bussink J; Scheijen B; Nagtegaal ID; van Laarhoven HW; Raleigh JA; Varia MA; Heuvel JJ; Rouschop KM; Sweep FC; Span PN
    Breast Cancer Res; 2011 Aug; 13(4):R82. PubMed ID: 21864376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Pan-Cancer Analysis Identified that TRIB3 was Associated with Immune Cell Infiltration and Poor Prognosis.
    Yu KX; Yuan WJ; Li J; Wang HZ; Li YX
    Curr Pharm Biotechnol; 2024 Sep; ():. PubMed ID: 39279106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIB3 facilitates glioblastoma progression via restraining autophagy.
    Tang Z; Chen H; Zhong D; Wei W; Liu L; Duan Q; Han B; Li G
    Aging (Albany NY); 2020 Nov; 12(24):25020-25034. PubMed ID: 33203798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer.
    Orea-Soufi A; Castillo-Lluva S; Salvador-Tormo N; Martín-Cabrera P; Recuero S; Gabicagogeascoa E; Moreno-Valladares M; Mendiburu-Eliçabe M; Blanco-Gómez A; Ramos-Pittol JM; García-Taboada E; Ocaña A; Cimas FJ; Matheu A; Álvarez-López I; Velasco G; Lorente M
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.
    Lin J; Xu X; Li T; Yao J; Yu M; Zhu Y; Sun D
    Front Oncol; 2021; 11():650678. PubMed ID: 34868901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients.
    Baran B; Sanlav G; Kızmazoğlu D; Kum Özşengezer S; Aktaş S; Altun Z; Olgun N
    Clin Med Insights Oncol; 2023; 17():11795549231199926. PubMed ID: 37744426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway.
    Qu J; Liu B; Li B; Du G; Li Y; Wang J; He L; Wan X
    Onco Targets Ther; 2019; 12():2235-2245. PubMed ID: 30988628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tribbles pseudokinase 3 inhibits the adipogenic differentiation of human adipose-derived mesenchymal stem cells].
    Bai XS; Lv LW; Zhou YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 52(1):1-9. PubMed ID: 32071456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation.
    Lee YC; Wang WL; Chang WC; Huang YH; Hong GC; Wang HL; Chou YH; Tseng HC; Lee HT; Li ST; Chen HL; Wu CC; Yang HF; Wang BY; Chang WW
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.